Dolby Laboratories

Historical 13F Holders

Symbol
DLB
CUSIP
25659T107
All holders as of
Q2 2026
Type
Equity
Class
COM CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 25659T107 since 12/18/2024, newest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A Amendment 2 10.0% 6/4/2026
Event 5/31/2026
Morgan Stanley 13G/A Amendment 5
8.2% 5/11/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 8.2% 4/29/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.2% 4/29/2026
Event 3/31/2026
Bank of New York Mellon Corp 13G/A Amendment 2
7.4% 4/28/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 14 0% 3/26/2026
Event 3/13/2026
Dagmar Dolby 13D/A Amendment 55
36.0% 2/13/2026
Event 2/11/2026
Morgan Stanley 13G/A Amendment 4
10.2% 2/11/2026
Event 12/31/2025
Vanguard Group Inc 13G/A Amendment 13 12.3% 4/30/2025
Event 3/31/2025
Bank of New York Mellon Corp 13G/A Amendment 1
9.3% 4/21/2025
Event 3/31/2025
Dagmar Dolby 13D/A Amendment 54
36.6% 2/3/2025
Event 1/30/2025
Bank of New York Mellon Corp 13G
8.0% 1/23/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 22 163 k $8.81 M
2026 Q2 401 65.6 M $3.33 B
2026 Q1 425 59.0 M $3.54 B
2025 Q4 411 58.7 M $3.77 B
2025 Q3 421 57.9 M $4.19 B
2025 Q2 414 58.0 M $4.31 B
2025 Q1 430 56.8 M $4.56 B
2024 Q4 438 57.3 M $4.47 B
2024 Q3 423 55.2 M $4.22 B
2024 Q2 440 61.4 M $4.86 B
2024 Q1 431 68.0 M $5.70 B
2023 Q4 443 61.9 M $5.33 B
2023 Q3 432 58.1 M $4.63 B
2023 Q2 431 54.8 M $4.61 B
2023 Q1 431 54.7 M $4.70 B
2022 Q4 406 57.4 M $4.05 B
2022 Q3 392 56.4 M $3.68 B
2022 Q2 377 59.6 M $4.27 B
2022 Q1 374 61.1 M $4.78 B
2021 Q4 382 60.4 M $5.75 B
2021 Q3 391 59.7 M $5.25 B
2021 Q2 392 60.8 M $5.98 B
2021 Q1 388 62.4 M $6.16 B
2020 Q4 358 62.7 M $6.09 B
2020 Q3 342 59.6 M $3.95 B
2020 Q2 319 59.9 M $3.95 B
2020 Q1 319 60.1 M $3.26 B
2019 Q4 336 59.6 M $4.10 B
2019 Q3 315 58.8 M $3.80 B
2019 Q2 324 59.5 M $3.84 B
2019 Q1 333 57.7 M $3.64 B
2018 Q4 317 58.6 M $3.62 B
2018 Q3 323 60.4 M $4.22 B
2018 Q2 289 59.4 M $3.66 B
2018 Q1 299 58.1 M $3.69 B
2017 Q4 296 55.2 M $3.42 B
2017 Q3 261 54.6 M $3.14 B
2017 Q2 270 52.9 M $2.59 B
2017 Q1 260 52.4 M $2.75 B
2016 Q4 290 52.8 M $2.39 B
2016 Q3 262 53.0 M $2.87 B
2016 Q2 256 50.7 M $2.43 B
2016 Q1 217 51.1 M $2.22 B
2015 Q4 212 50.3 M $1.69 B
2015 Q3 213 46.7 M $1.52 B
2015 Q2 213 48.1 M $1.91 B
2015 Q1 218 46.4 M $1.77 B
2014 Q4 212 47.3 M $2.04 B
2014 Q3 221 48.0 M $2.01 B
2014 Q2 214 48.6 M $2.10 B
2014 Q1 211 50.3 M $2.24 B